Australia, May 22 -- Amgen Inc., owns the trademark (2510981) for 'CONFIPEN' till Aug. 20, 2034.
Status: protected:
Registered/protected
Class: 5 [Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, immune, cardiovascular, metabolic and inflammatory diseases and conditions.]
Type of Mark: Word
Date of Acceptance: March 14
Registration Advertised: May 21
For further details contact Elsa D. Lemoine Amgen Inc. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2510981.
Disclaimer: Curated by HT Syndication....